Cefdinir Cas:91832-40-5

We are Cefdinir CAS:91832-40-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Description:

Product Name: Cefdinir CAS NO: 91832-40-5

 

Synonyms:

CI 983;

Novacef;

Omnice;

 

Chemical & Physical Properties:

Appearance: White powder

Assay :≥99.00%

Density: 1.89 g/cm3

Melting Point: >180℃ dec

Refractive Index: 1.861

Storage Condition: Room temp

Water Solubility: Soluble in water

 

Safety Information:

RTECS: XI0367250

HS Code: 2941905990

WGK Germany: 3

 

A Cephalosporin antibiotic structurally similar to Cefixime. Cefdinir (Omnicef) is a semi-synthetic, broad-spectrum antibiotic, which is proved to be effective for common bacterial infections of the ear, sinus, throat, and skin.Target: AntibacterialCefdinir is a third generation oral cephalosporin antibiotic. Cefdinir (Omnicef) is a semi-synthetic, broad-spectrum antibiotic in the third generation of the cephalosporin class, which is proved to be effective for common bacterial infections of the ear, sinus, throat, and skin. It can be used to treat infections caused by several Gram-negative and Gram-positive bacteria. It is available in US as Omnicef by Abbott Laboratories and in India as Cednir by Abbott, Kefnir by Glenmark and Cefdiel by Ranbaxy. As of 2008, cefdinir was the highest-selling cephalosporin antibiotic in the United States, with more than US$585 million in retail sales of its generic versions alone.Cefdinir, a new oral 2-amino-5-thiazolyl cephalosporin, inhibited the luminol-amplified chemiluminescence (LACL) response of human neutrophils stimulated by PMA but not opsonized zymosan, in a concentration-dependent but not time-dependent manner. The LACL response to opsonized zymosan in cytochalasin B-treated neutrophils was, however, inhibited by cefdinir. Furthermore, cefdinir inhibited LACL generation in cell-free systems consisting of H2O2, NaI, and either horseradish peroxidase or a myeloperoxidase-containing neutrophil extract. Orthodianisidine oxidation in these two acellular systems was inhibited by cefdinir.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.

Related Products:methyl 5,6-exo-epoxy-7-anti-trimethylsilylbicyclo(2.2.1)heptane-2-endo-carboxylate manufacturer | N-(3-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)phenyl)-2-(naphthalen-1-yl)acetamide supplier | diethyl 2,6-diisocyano-1,2,3,5,6,7-hexahydro-s-indacene-2,6-dicarboxylate producer.